Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study
BackgroundFibroblast growth factor 23 (FGF23) is emerging as a novel biomarker of bone metabolism, chronic kidney disease, and cardiovascular disease (CVD). However, its clinical correlates and potential predictive role in a community‐based setting are incompletely understood. Methods and ResultsWe...
Asıl Yazarlar: | , , , , , , , , , |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wiley
2016-07-01
|
Seri Bilgileri: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Konular: | |
Online Erişim: | https://www.ahajournals.org/doi/10.1161/JAHA.116.003486 |